Algry planning US launch for choline

Related tags Nutrition

Algry Quimica, the Spanish company which claims to be the leading
European manufacturer of choline ingredients for nutraceuticals and
infant formulas, has said it is on the verge of launching its USP
choline bitartrate and USP choline chloride products in the US.

Algry Quimica, the Spanish company which claims to be the leading European manufacturer of choline ingredients for nutraceuticals and infant formulas, has said it is on the verge of launching its USP choline bitartrate and USP choline chloride products in the US.

The move comes after the recent decision by the US Food and Drug Adminstration (FDA) allowing products containing qualifying amounts of choline to carry a nutrient label claim. Foods and supplements meeting these guidelines are able to claim they are a 'good source' or 'excellent source of choline.'

"We are very pleased with this decision, as choline is widely recognised as playing a key role in the structural integrity of cell membranes, processing dietary fat, reproductive development and neural functions, such as memory and muscle functions,"​ said Guillermo Rodriguez, worldwide sales manager at Algry Quimica.

"The FDA decision will enable our customers in the nutritional and food fields to actively promote the use of choline-based products, based on top quality raw materials from the European leader in the manufacturing of these compounds."

Algry Quimica also manufactures several types of choline for other applications, including choline dihydrogen citrate, mainly used for drinks. Choline chloride and choline bitartrate are mainly used in tableting, capsules and solid nutritional applications.

Related topics Markets and Trends